Spero Therapeutics, Inc.

/Spero Therapeutics, Inc.

They are a multi-asset, clinical-stage biopharmaceutical company focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections.

Symbol

Price Range
$14.00 - $16.00

Anticipated Shares
5,000,000

Effective Date
November 2, 2017

Underwriters

To view the prospectus for IPO, or any offering listed on ClickIPO,
download the ClickIPO app...

or a prospectus can be requested from G. Price at
ClickIPO Securities, LLC P. O. Box 21154, Mesa, AZ 85277

Secured By miniOrange